期刊文献+

Preventive effect of Peperomia pellucida(L.) Kunth herbs on ovariectomyinduced osteoporotic rats

Preventive effect of Peperomia pellucida(L.) Kunth herbs on ovariectomyinduced osteoporotic rats
原文传递
导出
摘要 Osteoporosis is a metabolic skeletal disorder leading to bone fracture which adversely impacts the quality of life. In the present, we aimed to investigate the effect of Peperomia pellucida(L.) Kunth herb juice and ethanolic extract on ovariectomy(OVX)-induced osteoporotic rat model. Osteoporosis was induced by OVX with a double dorsolateral approach on female Wistar rats. Female Wistar rats undergoing sham surgeries(sham-control group) served as controls. The ovariectomized rats were divided into six groups based on administered treatments,(i) CMC Na 0.3%(OVX-control group),(ii) standard drug(ethynil estradiol 4.5 μg/kg),(iii) P. pellucida juice at dose of 50 mg/kg, and(iv) 100 mg/kg,(v) P. pellucida ethanolic extract at dose of 50 mg/kg, and(vi) 100 mg/kg. Treatments were started 1 week after the surgeries and lasted for 6 weeks. Rats treated with 100 mg/kg P. pellucida ethanol extract had significantly decreased serum ALP level and reduced excretion of urine calcium compared with the OVX-control group(P<0.05). These levels were not significantly altered when compared with the sham-control group(P<0.05). Furthermore, 100 mg/kg ethanolic extract-treated group showed improvement on three-dimensional image of the trabecular bone compared with the OVX-control group. Trabecular cavity formation in 100 mg/kg ethanolic extract-treated group was minimal. Ethanolic extract of Peperomia pellucida(L.) Kunth herbs at a dose of 100 mg/kg had preventive effect on OVX-induced osteoporotic rats. Osteoporosis is a metabolic skeletal disorder leading to bone fracture which adversely impacts the quality of life. In the present, we aimed to investigate the effect of Peperomia pellucida (L.) Kunth herb juice and ethanolic extract on ovariectomy (OVX)-induced osteoporotic rat model. Osteoporosis was induced by OVX with a double dorsolateral approach on female Wistar rats. Female Wistar rats undergoing sham surgeries (sham-control group) served as controls. The ovariectomized rats were divided into six groups based on administered treatments, (i) CMC Na 0.3% (OVX-control group), (ii) standard drug (ethynil estradiol 4.5 pg/kg), (iii) P. pellucidajuice at dose of 50 mg/kg, and (iv) 100 mg/kg, (v) P. pellucida ethanolic extract at dose of 50 mg/kg, and (vi) 100 mg/kg. Treatments were started 1 week after the surgeries and lasted for 6 weeks. Rats treated with 100 mg/kg P. pellucida ethanol extract had significantly decreased serum ALP level and reduced excretion of urine calcium compared with the OVX-control group (P〈0.05). These levels were not significantly altered when compared with the sham-control group (P〈0.05). Furthermore, 100 mg/kg ethanolic extract-treated group showed improvement on three-dimensional image of the trabecular bone compared with the OVX-control group. Trabecular cavity formation in 100 mg/kg ethanolic extract-treated group was minimal. Ethanolic extract of Peperomia pellucida (L.) Kunth herbs at a dose of 100 mg/kg had preventive effect on OVX-induced osteoporotic rats.
出处 《Journal of Chinese Pharmaceutical Sciences》 CAS CSCD 2016年第7期546-551,共6页 中国药学(英文版)
关键词 OSTEOPOROSIS OVARIECTOMY PEPEROMIA pellucida(L.)Kunth Osteoporosis, Ovariectomy, Peperomia pellucida (L.) Kunth
  • 相关文献

参考文献12

  • 1O'Connell, M.B.; Vondracek, S.F. Osteoporosis and other metabolic bone diseases, in Pharmacotherapy: A Pathophysiologic Approach. 7th ed (Dipiro, J.T.; Talbert, R.L.; Yee, G.C.; Matzke, G.R.; Wells, B.G.; Posey, L.M. Eds.), New York, McGraw Hill, 2008, 1483-1504.
  • 2Chiechi, L.M.; Micheli, L. Curr. Top. Nutraceut. Res. 2005, 3, 15-28.
  • 3Mithal, A.; Ebeling, P.; Kyer, C.S. The Asia-Pasific regional audit: epidemiology, cost & burden of osteoporosis in 2013. Switzerland: International Osteoporosis Foundation. 2013, 56-60.
  • 4Xu, S.; Li, N.; Ning, M.M.; Zhou, C.H.; Yang, Q.R.; Wang, M.W. J. Nat. Prod. 2006, 69, 247-250.
  • 5Ngueguim, F.T.; Khan, M.P.; Donfack, J.H.; Tewari, D.; Dimo, T.; Maurya, R.; Chattopadhyay, N. J. Ethnopharmacol. 2013, 148, 62-68.
  • 6Gitelman, H.J. Anal. Biochem. 1967, 18, 521-531.
  • 7Jiang, J.M.Y.; Sacco, S.M.; Ward, W.E. J. Nutr. 2008, 138, 2106-2110.
  • 8Lim, D.W.; Kim, J.G.; Lee, Y.; Cha, S.H.; Kim, Y.T. Molecules. 2013, 18, 7998-8008.
  • 9Kini, U.; Nandeesh, B.N. Physiology of bone formation, remodeling, and metabolism, in Radionuclide and Hybrid Bone Imaging (Fogelman, I.; Gnanasegaran, G.; Van der Wall, H. Eds.), Springer-Verlag, Berlin, 2012, 132.
  • 10Dick, I.M.; Devine, A.; Beilby, J.; Prince, R.L. Am. J. Physiol. Endocrinol. Metab. 2005, 288, 430-435.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部